













|
|
paliperidone |
| Invega |
Pharmaceutical
company:
Ortho-McNeil-Janssen Pharmaceuticals, Inc. www.invega.com |
NEW INDICATION & DOSAGE
Monotherapy or adjunct to mood stabilizers, antidepressants, or both for acute treatment of schizoaffective disorder—
Adults: 6 mg P.O. daily, in the morning. Adjust dosage in 3-mg increments at more than 4-day intervals according to patient response; recommended dosage range, 3 to 12 mg daily.
ADJUST-A-DOSE: If creatinine clearance is 79 ml/minute to 50 ml/minute, initially give 3 mg P.O. once daily. May increase dose to a maximum of 6 mg once daily as tolerated, based on clinical response. If creatinine clearance is 49 ml/minute to 10 ml/minute, initially give 1.5 mg P.O. once daily, increase to maximum dose of 3 mg once daily, as tolerated. Drug isn't recommended in patients with a creatinine clearance less than 10 ml/minute.
Home - Guest
Registry - Customer Service
Brought to you by
Lippincott Williams & Wilkins, publisher of Lippincott's Nursing Drug Guide.
For help on how you should use this site, see our Disclaimer.
© Copyright 2010 by Lippincott Williams & Wilkins
|